 Dr Moulemanns has inspected the documents in question which include internal research documents such as laboratory notebooks of the inventors of the Patent and internal research documents which include research on matters unrelated to the invention claimed in the Patent.
 As to in-house research documents he says that Dr Moulemanns appears to accept the primary relevance of this material but indicates the documents may also contain information which is not relevant to the present proceedings.
 As to documents relating to recent internal Bayer research, Dr Cusick says that these are relevant and that Professor Adang will be required to view and consider them in order to complete his evidence. 18 Importantly, Dr Cusick states that Dr Moulemanns "emphasises the confidential and commercially sensitive nature of certain passages of the documents in issue.
